DCF — MARINHEALTH MEDICAL CENTER
Enterprise Value: $-480.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-480.7M
Enterprise Value
$-158.5M
PV of Cash Flows
$-322.1M
PV of Terminal Value
$-518.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $493.2M | $-26.4M | -5.0% | $-47.3M | $-43.0M |
| Year 2 | $508.0M | $-22.1M | -4.0% | $-43.6M | $-36.1M |
| Year 3 | $523.3M | $-17.6M | -3.0% | $-39.7M | $-29.8M |
| Year 4 | $539.0M | $-15.4M | -3.0% | $-38.2M | $-26.1M |
| Year 5 | $555.1M | $-14.5M | -3.0% | $-38.0M | $-23.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-480.7M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$478.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.0585511446372809
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5